The Marquie Group Joins Forces with City of Hope to Combat Metastatic Triple-Negative Breast Cancer
The Marquie Group (OTCMKTS: TMGI) has announced a collaboration with City of Hope to support research on metastatic triple-negative breast cancer (mTNBC) using ivermectin. The company will contribute through two main initiatives:
1. Donating 10% of Simply Whim product sales to Dr. Peter P. Lee's research at the Department of Immuno-Oncology at Beckman Research Institute
2. Broadcasting nationwide radio commercials on its Music of Your Life network to drive donations to a dedicated City of Hope landing page
Dr. Lee's team is currently conducting clinical trials examining optimal dosages of ivermectin in combination with immunotherapy for mTNBC patients. The research focuses on this aggressive breast cancer subtype due to its treatment options. The collaboration aims to address funding challenges while raising awareness about TNBC research needs.
Il Marquie Group (OTCMKTS: TMGI) ha annunciato una collaborazione con City of Hope per supportare la ricerca sul cancro al seno triplo negativo metastatico (mTNBC) utilizzando l'ivermectina. L'azienda contribuirà attraverso due iniziative principali:
1. Donando il 10% delle vendite dei prodotti Simply Whim alla ricerca del Dr. Peter P. Lee presso il Dipartimento di Immuno-Oncologia del Beckman Research Institute
2. Trasmettendo spot pubblicitari radiofonici a livello nazionale sulla sua rete Music of Your Life per promuovere donazioni a una pagina dedicata di City of Hope
Il team del Dr. Lee sta attualmente conducendo studi clinici per esaminare i dosaggi ottimali di ivermectina in combinazione con l'immunoterapia per i pazienti con mTNBC. La ricerca si concentra su questo sottotipo aggressivo di cancro al seno a causa delle sue opzioni di trattamento. La collaborazione mira ad affrontare le sfide di finanziamento mentre aumenta la consapevolezza sulle necessità di ricerca relative al TNBC.
El Marquie Group (OTCMKTS: TMGI) ha anunciado una colaboración con City of Hope para apoyar la investigación sobre el cáncer de mama triple negativo metastásico (mTNBC) utilizando ivermectina. La empresa contribuirá a través de dos iniciativas principales:
1. Donando el 10% de las ventas de los productos Simply Whim a la investigación del Dr. Peter P. Lee en el Departamento de Inmuno-Oncología del Beckman Research Institute
2. Transmitiendo comerciales de radio a nivel nacional en su red Music of Your Life para impulsar donaciones a una página dedicada de City of Hope
El equipo del Dr. Lee está llevando a cabo ensayos clínicos que examinan las dosis óptimas de ivermectina en combinación con inmunoterapia para pacientes con mTNBC. La investigación se centra en este subtipo agresivo de cáncer de mama debido a sus opciones de tratamiento. La colaboración tiene como objetivo abordar los desafíos de financiamiento mientras se aumenta la conciencia sobre las necesidades de investigación del TNBC.
마르키 그룹 (OTCMKTS: TMGI)가 시티 오브 호프와 협력하여 메타스타틱 삼중 음성 유방암(mTNBC)에 대한 연구를 지원하기 위해 이버멕틴을 사용할 것이라고 발표했습니다. 회사는 두 가지 주요 이니셔티브를 통해 기여할 것입니다:
1. Simply Whim 제품 판매의 10%를 Beckman Research Institute의 면역 종양학과에서 Peter P. Lee 박사의 연구에 기부
2. Music of Your Life 네트워크에서 전국적으로 라디오 광고를 방송하여 City of Hope의 전용 랜딩 페이지로 기부를 유도
Lee 박사 팀은 현재 mTNBC 환자를 위한 면역 요법과 함께 이버멕틴의 최적 용량을 조사하는 임상 시험을 진행하고 있습니다. 이 연구는 치료 옵션이 제한된 이 공격적인 유방암 아형에 초점을 맞추고 있습니다. 이 협력은 자금 조달 문제를 해결하고 TNBC 연구의 필요성에 대한 인식을 높이는 것을 목표로 하고 있습니다.
Le Marquie Group (OTCMKTS: TMGI) a annoncé une collaboration avec City of Hope pour soutenir la recherche sur le cancer du sein triple négatif métastatique (mTNBC) en utilisant l'ivermectine. L'entreprise contribuera par le biais de deux initiatives principales :
1. En faisant don de 10 % des ventes des produits Simply Whim à la recherche du Dr Peter P. Lee au Département d'immuno-oncologie de l'Institut de recherche Beckman
2. En diffusant des publicités radio à l'échelle nationale sur son réseau Music of Your Life pour inciter les dons vers une page d'accueil dédiée de City of Hope
Le groupe du Dr Lee mène actuellement des essais cliniques pour examiner les dosages optimaux d'ivermectine en combinaison avec l'immunothérapie pour les patients atteints de mTNBC. La recherche se concentre sur ce sous-type agressif de cancer du sein en raison de ses options de traitement limitées. La collaboration vise à relever les défis de financement tout en sensibilisant aux besoins de recherche sur le TNBC.
Die Marquie Group (OTCMKTS: TMGI) hat eine Zusammenarbeit mit City of Hope angekündigt, um die Forschung zu metastasierendem dreifach negativem Brustkrebs (mTNBC) unter Verwendung von Ivermectin zu unterstützen. Das Unternehmen wird durch zwei Hauptinitiativen beitragen:
1. Spenden von 10% des Verkaufs der Simply Whim Produkte an die Forschung von Dr. Peter P. Lee am Department of Immuno-Oncology des Beckman Research Institute
2. Ausstrahlung von landesweiten Radio-Werbespots über ihr Netzwerk Music of Your Life, um Spenden für eine spezielle Landingpage von City of Hope zu fördern
Das Team von Dr. Lee führt derzeit klinische Studien durch, um die optimalen Dosierungen von Ivermectin in Kombination mit Immuntherapie für mTNBC-Patienten zu untersuchen. Die Forschung konzentriert sich auf diesen aggressiven Brustkrebs-Subtyp aufgrund seiner begrenzten Behandlungsoptionen. Die Zusammenarbeit zielt darauf ab, Finanzierungsschwierigkeiten zu bewältigen und gleichzeitig das Bewusstsein für die Forschungsbedürfnisse von TNBC zu schärfen.
- Partnership with major cancer research institution (City of Hope)
- Revenue diversification through charitable initiative
- Potential brand value enhancement through social responsibility
- 10% of Simply Whim sales being redirected to donations may impact profit margins
ST. PETERSBURG, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- The Marquie Group, Inc. (OTCMKTS: TMGI) is proud to announce that it is supporting Peter P. Lee, M.D., Chair of the Department of Immuno-Oncology at Beckman Research Institute at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, to raise awareness and funds for groundbreaking research on metastatic triple-negative breast cancer (mTNBC) using ivermectin.
Through its subsidiaries, Simply Whim and Music of Your Life, The Marquie Group is supporting Dr. Lee’s innovative work by donating
CEO Marc Angell on Supporting this Research
Marc Angell, CEO of The Marquie Group, shared the personal motivation behind this initiative, “When the founder of Simply Whim was diagnosed with metastatic triple-negative breast cancer a few years ago, I reached out to Dr. Lee after reading about his incredible work with ivermectin. While ivermectin alone may not prevent cancer recurrence, Dr. Lee’s team has achieved positive results when combining it with other drugs.” Angell emphasized the importance of funding for such projects, “Dr. Lee noted that securing financial support is a constant challenge for these types of studies. By leveraging our radio network and collaborating with City of Hope, we aim to drive donations directly to his research. The team at City of Hope has been incredibly supportive in making this happen.”
Dr. Peter P. Lee’s Research on TNBC with Ivermectin
Dr. Lee and his team are now in the clinical trial phase, focusing on patients with a specific type of breast cancer known as “metastatic triple-negative breast cancer” (mTNBC). This subtype of breast cancer is considered particularly aggressive and has relatively limited treatment options, making this research especially important. This trial examines the optimal dosages of the two drugs in a small and targeted group of patients, with expansion to evaluate the treatment's effectiveness.
Dr. Lee noted, “I'm grateful to Mr. Angell for this opportunity to support our work, and very optimistic about the potential of ivermectin in combination with immunotherapy against breast cancer and other tumor types.”
Looking Ahead
City of Hope has launched a dedicated landing page where Music of Your Life listeners and other supporters can contribute directly to Dr. Lee’s work. Additional details will be shared as the campaign progresses. This collaboration underscores Simply Whim’s commitment to making a meaningful impact in the fight against TNBC while raising awareness about the critical need for funding in cancer research.
We caution against unsupervised use of ivermectin.
For The Marquie Group:
Marc Angell, Chief Executive Officer
800-351-3021
marc@tmgiusa.com
For City of Hope:
Dr. Peter P. Lee, M.D.
Chair, Department of Immuno-Oncology, Beckman Research Institute
626-613-6348
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements contained in this press release that are not historical facts are forward-looking statements and include, for example, statements regarding, among other things, the plans, strategies, and prospects, both business and financial, of TMGI. We have based these forward-looking statements on our current expectations about future events, including the rollout of products and features and the future plans, timing and potential success of our future collaborations. The forward-looking statements included in this press release are based on our current beliefs and expectations of our management as of the date of this press release. These statements are not guarantees or indicative of future performance. Although we believe that our plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "will," "should," "seeks," "plans," "scheduled," "anticipates," "soon," "goal," "intends," or similar expressions. Forward-looking statements are not guarantees of future performance, and involve risks, uncertainties and assumptions that may cause our actual results to differ materially from the expectations that we describe in our forward-looking statements. There may be events in the future that we are not accurately able to predict, or over which we have no control.
Important assumptions and other important factors that could cause actual results to differ materially from those forward-looking statements include, but are not limited to, our ability to recognize the anticipated benefits of Simply Whim, Music of Your Life, and others including our future collaborations; the possibility that we may be adversely impacted by economic, business, and/or competitive factors; our limited operating history making it difficult to evaluate our business and prospects; our inability to effectively manage future growth and achieve operational efficiencies; our inability to grow or maintain our active customer base; our inability to achieve or maintain profitability; occurrence of a cyber incident resulting in information theft, data corruption, operational disruption and/or financial loss; potential diversion of management's attention and consumption of resources as a result of new products and strategies; and those additional risks, uncertainties and factors described in more detail under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended May 31, 2024, and in our other filings with the Securities and Exchange Commission. We do not intend, and, except as required by law, we undertake no obligation, to update any of our forward-looking statements after the issuance of this press release to reflect any future events or circumstances. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
FAQ
What is The Marquie Group's (TMGI) contribution to City of Hope's cancer research?
What type of cancer research is TMGI supporting at City of Hope?
How can people contribute to Dr. Lee's research through TMGI's initiative?
What stage is Dr. Lee's cancer research currently in at City of Hope?
